推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-54106218，021-33363733

chinasupport@letpub.com

登录 注册 新注册优惠

Carcinoma of Unknown Primary

H Takei… - Diagnostic Molecular Pathology in Practice, 2011 - Springer
A 74-year-old woman presented with seizures and change in mental status. An MRI of the brain
revealed a single ring-enhancing 1.6 × 2.1 × 2.1 cm mass with surrounding prominent edema
in the deep white mat- ter of the left posterior parietal region. The radiologi- cal differential ...

[PDF] Carcinoma of Unknown Primary

[PDF] from mi-osteopathic.orgB Hitzelberger - 2011 - mi-osteopathic.org
... NOT routinely recommended in evaluation NOT routinely recommended in evaluation of
carcinoma of unknown primary Page 24. Role for PET/CT?? ... Page 56. Squamous Cell Carcinoma
of Unknown Primary Paclitaxel 175mg/m2 IV Day #1 Cisplatin 100mg/m2 IV Day #2 ...
Related articles - View as HTML

18F-FDG PET/CT as a Diagnostic Tool in Patients with Extracervical Carcinoma of Unknown Primary Site: A Literature Review

A Loft, AK Berthelsen, KD Pedersen, J Graff… - The …, 2011 - AlphaMed Press
Abstract Background. Carcinoma of unknown primary (CUP) represents a heterogeneous group
of metastatic malignancies for which no primary tumor site can be identified after extensive diagnostic
workup. Failure to identify the primary site may negatively influence patient management. ...
All 2 versions

[PDF] Molecular Tumor Profiling in the Diagnosis of Patients with Carcinoma of Unknown Primary Site: Retrospective Evaluation of Gene Microarray Assay

[PDF] from omicsonline.orgJD Hainsworth, R Pillai, WD Henner… - J Mol Biomark …, 2011 - omicsonline.org
Carcinoma of unknown primary site (CUP) is a relatively common clinical syndrome, accounting
for approximately 2-5% of all cancer diagnoses. Although several clinical subsets with specific
treatment implications have been identified, the majority of patients receive empiric ...
Related articles - View as HTML

Prospective Gene Signature Study Using microRNA to Identify the Tissue of Origin in Patients with Carcinoma of Unknown Primary

GR Varadhachary, Y Spector, JL Abbruzzese… - Clinical Cancer …, 2011 - AACR
Results: Seventy-four of the 87 cases were processed successfully. The assay result was consistent
or compatible with the clinicopathologic features in 84% of cases processed successfully
(71% of all samples attempted). In 65 patients, pathology and immunohistochemistry ...
Related articles - All 3 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451